Andrew R Curran, DO | |
1188 W University Dr, Boise, ID 83706 | |
(208) 336-8250 | |
(208) 345-9514 |
Full Name | Andrew R Curran |
---|---|
Gender | Male |
Speciality | Orthopedic Surgery |
Experience | 30 Years |
Location | 1188 W University Dr, Boise, Idaho |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1093705071 | NPI | - | NPPES |
1093705071 | Medicaid | ID |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207X00000X | Orthopaedic Surgery | O-218 (Idaho) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Treasure Valley Hospital | Boise, ID | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Idaho Sports Medicine Institute, Pa | 1759278765 | 12 |
News Archive
The Food and Drug Administration (FDA) today announced a broader import control of all farm-raised catfish, basa, shrimp, dace (related to carp), and eel from China.
IMS Health, the world's leading provider of market intelligence to the pharmaceutical and healthcare industries, today announced the launch of IMS MIDAS Global Biologics™, a powerful offering that enables the company's clients to make more confident decisions as they assess opportunities in the fast-growing, $120 billion worldwide biologics market.
The Premier healthcare alliance today announced that Carolinas Medical Center NorthEast (CMC-NorthEast) of Concord, N.C., selected Premier's QualityAdvisor™ solution to improve delivery of patient care and safely reduce costly avoidable patient events.
SAGE Therapeutics, a biopharmaceutical company developing novel medicines to treat life-threatening and rare central nervous system (CNS) disorders, today announced dose initiation of the first patient in a Phase 1/2 clinical trial of SAGE-547, a neuroactive steroid, in super-refractory status epilepticus (SRSE), a critical condition in which the brain is in a state of persistent seizure.
› Verified 7 days ago
Entity Name | Idaho Sports Medicine Institute, Pa |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1154356624 PECOS PAC ID: 1759278765 Enrollment ID: O20040303001050 |
News Archive
The Food and Drug Administration (FDA) today announced a broader import control of all farm-raised catfish, basa, shrimp, dace (related to carp), and eel from China.
IMS Health, the world's leading provider of market intelligence to the pharmaceutical and healthcare industries, today announced the launch of IMS MIDAS Global Biologics™, a powerful offering that enables the company's clients to make more confident decisions as they assess opportunities in the fast-growing, $120 billion worldwide biologics market.
The Premier healthcare alliance today announced that Carolinas Medical Center NorthEast (CMC-NorthEast) of Concord, N.C., selected Premier's QualityAdvisor™ solution to improve delivery of patient care and safely reduce costly avoidable patient events.
SAGE Therapeutics, a biopharmaceutical company developing novel medicines to treat life-threatening and rare central nervous system (CNS) disorders, today announced dose initiation of the first patient in a Phase 1/2 clinical trial of SAGE-547, a neuroactive steroid, in super-refractory status epilepticus (SRSE), a critical condition in which the brain is in a state of persistent seizure.
› Verified 7 days ago
Mailing Address | Practice Location Address |
---|---|
Andrew R Curran, DO 1188 W University Dr, Boise, ID 83706-3009 Ph: (208) 336-8250 | Andrew R Curran, DO 1188 W University Dr, Boise, ID 83706 Ph: (208) 336-8250 |
News Archive
The Food and Drug Administration (FDA) today announced a broader import control of all farm-raised catfish, basa, shrimp, dace (related to carp), and eel from China.
IMS Health, the world's leading provider of market intelligence to the pharmaceutical and healthcare industries, today announced the launch of IMS MIDAS Global Biologics™, a powerful offering that enables the company's clients to make more confident decisions as they assess opportunities in the fast-growing, $120 billion worldwide biologics market.
The Premier healthcare alliance today announced that Carolinas Medical Center NorthEast (CMC-NorthEast) of Concord, N.C., selected Premier's QualityAdvisor™ solution to improve delivery of patient care and safely reduce costly avoidable patient events.
SAGE Therapeutics, a biopharmaceutical company developing novel medicines to treat life-threatening and rare central nervous system (CNS) disorders, today announced dose initiation of the first patient in a Phase 1/2 clinical trial of SAGE-547, a neuroactive steroid, in super-refractory status epilepticus (SRSE), a critical condition in which the brain is in a state of persistent seizure.
› Verified 7 days ago
Tracye Jean-marie Lawyer, MD, PHD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 8950 W Emerald St Ste 168, Boise, ID 83704 Phone: 208-321-1209 Fax: 208-321-1211 | |
Dustin I Judd, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 600 N Robbins Rd, Suite 100, Boise, ID 83702 Phone: 208-383-0201 | |
Dr. Michael Glover, M.D. Orthopedic Surgery Medicare: Medicare Enrolled Practice Location: 500 W Fort St, Mail Code #112, Boise, ID 83702 Phone: 208-422-1000 Fax: 208-422-1082 | |
Jeffrey D Smith, PA C Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 7979 W Rifleman St, Boise, ID 83704 Phone: 208-989-0598 | |
Howard A King, MD Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 600 N Robbins Rd, Ste 100, Boise, ID 83702 Phone: 208-383-0201 Fax: 208-489-4300 | |
Dr. Jeffrey Glenn Hessing, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 8854 W Emerald St, Suite 140, Boise, ID 83704 Phone: 208-327-4790 Fax: 208-367-4888 | |
Dr. Kirk J Lewis, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1188 University Dr, Boise, ID 83706 Phone: 208-336-8250 Fax: 208-345-9514 |